GW&K Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$90.1M Buy
1,393,875
+139,227
+11% +$9.81M 0.79% 26
2025
Q4
$84.4M Sell
1,254,648
-7,069
-0.6% -$476K 0.73% 24
2025
Q3
$92.5M Sell
1,261,717
-162,799
-11% -$10.8M 0.82% 18
2025
Q2
$74.1M Sell
1,424,516
-40,375
-3% -$2.3M 0.66% 28
2025
Q1
$93.5M Sell
1,464,891
-280,750
-16% -$16.3M 0.87% 17
2024
Q4
$83.5M Sell
1,745,641
-16,620
-0.9% -$852K 0.71% 27
2024
Q3
$101M Sell
1,762,261
-417,744
-19% -$23.9M 0.86% 14
2024
Q2
$114M Sell
2,180,005
-16,872
-0.8% -$740K 1.04% 8
2024
Q1
$89.4M Sell
2,196,877
-29,661
-1% -$1.11M 0.79% 21
2023
Q4
$82.3M Sell
2,226,538
-117,767
-5% -$4.44M 0.77% 20
2023
Q3
$89.6M Sell
2,344,305
-35,284
-1% -$1.45M 0.9% 10
2023
Q2
$85.8M Sell
2,379,589
-22,526
-0.9% -$769K 0.81% 18
2023
Q1
$91.7M Buy
2,402,115
+313,259
+15% +$14.7M 0.89% 14
2022
Q4
$119M Sell
2,088,856
-114,186
-5% -$5.85M 1.21% 7
2022
Q3
$87.1M Buy
2,203,042
+559,654
+34% +$24.7M 0.96% 13
2022
Q2
$72.3M Sell
1,643,388
-10,471
-0.6% -$453K 0.78% 21
2022
Q1
$66M Buy
1,653,859
+95,215
+6% +$3.39M 0.59% 47
2021
Q4
$62.7M Buy
1,558,644
+59,875
+4% +$2.24M 0.52% 66
2021
Q3
$61M Buy
1,498,769
+435,575
+41% +$18.2M 0.54% 57
2021
Q2
$48.3M Buy
1,063,194
+1,964
+0.2% +$86.9K 0.42% 94
2021
Q1
$44.2M Buy
1,061,230
+218,975
+26% +$10M 0.41% 101
2020
Q4
$36M Buy
+842,255
New +$30.3M 0.38% 118

Other funds holding HALO

GW&K Investment Management's HALO Position: Q1 2026 in Review

GW&K Investment Management increased its Halozyme (HALO) stake by 11% in Q1 2026, buying an estimated $9.81M and bringing the position to 1,393,875 shares worth $90.1M. The position accounts for 0.79% of the portfolio, ranked #26.

GW&K Investment Management first reported a position in HALO in Q4 2020 and has held it in 22 quarters since. The position peaked at $119M in Q4 2022. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • GW&K Investment Management held 1,393,875 shares of Halozyme worth $90.1M as of Q1 2026.
  • GW&K Investment Management bought 139,227 Halozyme shares in Q1 2026, an estimated $9.81M.
  • Halozyme made up 0.79% of GW&K Investment Management's portfolio in Q1 2026, its #26 holding.
  • GW&K Investment Management first reported a position in Halozyme in Q4 2020 and has held it in 22 quarters since.
  • GW&K Investment Management's Halozyme position peaked at $119M in Q4 2022.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.